3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Oropharyngeal Neoplasms
12
Lung Neoplasms
9
Carcinoma
8
Mouth Neoplasms
7
Laryngeal Neoplasms
7
Mesothelioma, Malignant
6
Hypopharyngeal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Uterine Cervical Neoplasms
5
Nasopharyngeal Carcinoma
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Triple Negative Breast Neoplasms
3
Salivary Gland Neoplasms
3
Lymphoid Interstitial Pneumonia
3
Gallbladder Neoplasms
3
Testicular Neoplasms
2
Seminoma
2
Medulloblastoma
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Interventions
Cyclophosphamide
26
fludarabine
18
Dexamethasone
17
pembrolizumab
12
Rituximab
11
Etoposide
10
venetoclax
9
pomalidomide
9
Gemcitabine
9
fludarabine phosphate
7
daratumumab
7
Lenalidomide
7
Bortezomib
7
carfilzomib
6
obinutuzumab
5
glofitamab
5
Vincristine
5
Temozolomide
5
Prednisone
5
Nivolumab
5
Immunotherapy, Adoptive
5
Cisplatin
5
Calcium Dobesilate
5
selinexor
4
cemiplimab
4
Doxorubicin
4
Cytarabine
4
Carboplatin
4
zanubrutinib
3
ruxolitinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Platinum
×
90 days
×
Clear all
No trials found.